
    
      The 3D echocardiography could provide early and detailed information about the changes in the
      left and right ventricle.

      The prediction of sclerodermia associated pulmonary arterial hypertension (PAH) is rather
      adverse, so it makes sense to evaluate relevant changes of the left-ventricular longitudinal
      strain soon to adapt the PAH specific therapy accordingly.
    
  